Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma
Author:
Affiliation:
1. Department of Medicine V; Heidelberg University; Heidelberg Germany
2. Institute of Medical Biometry; Heidelberg University; Heidelberg Germany
3. National Center for Tumor Diseases; Heidelberg University; Heidelberg Germany
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jca.21323/fullpdf
Reference20 articles.
1. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation;Wuchter;Biol Blood Marrow Transplant,2010
2. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4;Fricker;Biochem Pharmacol,2006
3. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma;Devine;J Clin Oncol,2004
4. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone;Flomenberg;Blood,2005
5. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G‐CSF versus G‐CSF only: A single‐center retrospective analysis;Transfusion;2024-04-10
2. Mobilization and Collection of HSC;The EBMT Handbook;2024
3. Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma;Transfusion;2023-10-18
4. A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation;Transfusion Medicine and Hemotherapy;2023-10-16
5. Stem Cell Mobilization, Collection, and Processing;Transfusion Medicine and Hemotherapy;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3